At close: December 13 at 4:00:01 PM EST
After hours: 7:59:41 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 2 | 3 |
| Avg. Estimate | -2.58 | 0 | -11.97 | -3.81 |
| Low Estimate | -2.76 | 0 | -12.2 | -5.45 |
| High Estimate | -2.39 | 0 | -11.74 | -1.86 |
| Year Ago EPS | -3.75 | -- | -27 | -11.97 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | -- | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | 250k | -- |
| Sales Growth (year/est) | 0.00% | -- | -100.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -5.18 | -3.75 | -2.93 | -3.36 |
| EPS Actual | -3.75 | -4.59 | -3.32 | -2.32 |
| Difference | 1.42 | -0.84 | -0.39 | 1.04 |
| Surprise % | 27.54% | -22.40% | -13.31% | 30.85% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -2.58 | 0 | -11.97 | -3.81 |
| 7 Days Ago | -2.76 | 0 | -12.2 | -4.78 |
| 30 Days Ago | -2.33 | 0 | -13.33 | -9.11 |
| 60 Days Ago | -2.33 | 0 | -13.33 | -9.11 |
| 90 Days Ago | -3.1 | 0 | -13.55 | -8.82 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | 2 | -- | 2 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PALI | 31.33% | -- | 55.67% | 68.17% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Initiated | Brookline Capital: Buy | 11/20/2024 |
| Maintains | Maxim Group: Buy to Buy | 11/13/2024 |
| Reiterates | Maxim Group: Buy to Buy | 5/1/2024 |
| Maintains | Maxim Group: Buy to Buy | 4/16/2024 |
| Upgrade | Maxim Group: Hold to Buy | 11/17/2023 |
| Maintains | Ladenburg Thalmann: Buy to Buy | 5/16/2023 |
Related Tickers
TRVI Trevi Therapeutics, Inc.
4.1700
+15.83%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.8100
+2.26%
PBM Psyence Biomedical Ltd.
1.8500
-9.31%
CMRX Chimerix, Inc.
2.9500
+0.34%
PCSA Processa Pharmaceuticals, Inc.
1.1100
-11.20%
SLXN Silexion Therapeutics Corp
3.5200
+5.39%
CDIO Cardio Diagnostics Holdings, Inc.
1.2600
+5.00%
CRDF Cardiff Oncology, Inc.
3.9200
+19.88%
DBVT DBV Technologies S.A.
3.5700
-7.03%
CDT Conduit Pharmaceuticals Inc.
0.0815
-0.61%